Gene · 122876
Papers2,598
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,598
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In silico identification of 20S proteasome-β5 subunit inhibitors using structure-based virtual screening. | J Biomol Struct Dyn | 2024 | 37403265 | PubTator, text mining | PubMed |
| Automatic approach-avoidance tendency toward physical activity, sedentary, and neutral stimuli as a function of age, explicit affective attitude, and intention to be active. | Peer Community J | 2023 | 39659553 | PubTator, text mining | PubMed |
| Decoding the secrets: how conformational and structural regulators inhibit the human 20S proteasome. | Front Chem | 2023 | 38260042 | PubTator, text mining | PubMed |
| Lower-Risk Myelodysplastic Syndrome (MDS) Patients Exhibit Diminished Proteasome Proteolytic Activity and High Intracellular Reactive Oxygen Species (ROS) Levels. | Cureus | 2023 | 38169896 | PubTator, text mining | PubMed |
| Investigation on Electrospun and Solvent-Casted PCL-PLGA Blends Scaffolds Embedded with Induced Pluripotent Stem Cells for Tissue Engineering. | Pharmaceutics | 2023 | 38140077 | PubTator, text mining | PubMed |
| New Insights for Polyphenolic Compounds as Naturally Inspired Proteasome Inhibitors. | Pharmaceuticals (Basel) | 2023 | 38139838 | PubTator, text mining | PubMed |
| Acceleration of Protein Degradation by 20S Proteasome-Binding Peptides Generated by In Vitro Artificial Evolution. | Int J Mol Sci | 2023 | 38139315 | PubTator, text mining | PubMed |
| Proteomic Analysis of Human iPSC-Derived Neural Stem Cells and Motor Neurons Identifies Proteasome Structural Alterations. | Cells | 2023 | 38132120 | PubTator, text mining | PubMed |
| Marine Protected Area Expansion and Country-Level Age-Standardized Adult Mortality. | Ecohealth | 2023 | 38114749 | PubTator, text mining | PubMed |
| Cellular microenvironment: a key for tuning mesenchymal stem cell senescence. | Front Cell Dev Biol | 2023 | 38111850 | PubTator, text mining | PubMed |
| Adjustment for collider bias in the hospitalized Covid-19 setting. | Glob Epidemiol | 2023 | 38111522 | PubTator, text mining | PubMed |
| Structures revealing mechanisms of resistance and collateral sensitivity of Plasmodium falciparum to proteasome inhibitors. | Nat Commun | 2023 | 38097652 | PubTator, text mining | PubMed |
| Rational design of proteasome inhibitors based on the structure of the endogenous inhibitor PI31/Fub1. | Proc Natl Acad Sci U S A | 2023 | 38091293 | PubTator, text mining | PubMed |
| The moderation effect of social capital in the relationship between own income, social comparisons and subjective well-being: Evidence from four international datasets. | PLoS One | 2023 | 38060523 | PubTator, text mining | PubMed |
| Betapapillomavirus natural history and co-detection with alphapapillomavirus in cervical samples of adult women. | J Med Virol | 2023 | 38054528 | PubTator, text mining | PubMed |
| Call for emergency action to restore dietary diversity and protect global food systems in times of COVID-19 and beyond: Results from a cross-sectional study in 38 countries. | Heliyon | 2023 | 38045218 | PubTator, text mining | PubMed |
| Whole exome sequencing of patients with varicella-zoster virus and herpes simplex virus induced acute retinal necrosis reveals rare disease-associated genetic variants. | Front Mol Neurosci | 2023 | 38025266 | PubTator, text mining | PubMed |
| IMiD-Free Interval and IMiDs Sequence: Which Strategy Is Better Suited for Lenalidomide-Refractory Myeloma? | Life (Basel) | 2023 | 38004369 | PubTator, text mining | PubMed |
| Structural Basis of Clostridium perfringens Enterotoxin Activation and Oligomerization by Trypsin. | Toxins (Basel) | 2023 | 37999500 | PubTator, text mining | PubMed |
| New insights into the regulation of METTL3 and its role in tumors. | Cell Commun Signal | 2023 | 37996892 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/122876/papers?page=5